Zhanyu Wang
State Key Laboratory Of Natural Medicines, Jiangsu Key Laboratory Of Carcinogenesis And Intervention
Nanjing, China
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Targeting lysosomal HSP70 induces acid sphingomyelinase-mediated disturbance of lipid metabolism and leads to cell death in T cell malignancies.
Journal: Clinical and translational medicine
Published: November 08, 2022
Pharmacologic targeting of the P-TEFb complex as a therapeutic strategy for chronic myeloid leukemia.
Journal: Cell communication and signaling : CCS
Published: March 03, 2021
One-Two Punch Therapy for the Treatment of T-Cell Malignancies Involving p53-Dependent Cellular Senescence.
Journal: Oxidative medicine and cellular longevity
Published: February 13, 2021
Cholesterol-associated lysosomal disorder triggers cell death of hematological malignancy: Dynamic analysis on cytotoxic effects of LW-218.
Journal: Acta pharmaceutica Sinica. B
Published: October 15, 2020
Natural HDAC-1/8 inhibitor baicalein exerts therapeutic effect in CBF-AML.
Journal: Clinical and translational medicine
Published: April 23, 2020
Involvement of p53 Acetylation in Growth Suppression of Cutaneous T-Cell Lymphomas Induced by HDAC Inhibition.
Journal: The Journal of investigative dermatology
Published: August 21, 2019
GL-V9 exerts anti-T cell malignancies effects via promoting lysosome-dependent AKT1 degradation and activating AKT1/FOXO3A/BIM axis.
Journal: Free radical biology & medicine
Published: June 28, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026